Share

April 09, 2019; 92 (15 Supplement) May 9, 2019

Multiple Sclerosis and Use of Medical Cannabis: A Retrospective Review Evaluating Symptom Outcomes (P5.2-106)

Katelyn McCormack, Emily Lewandowski, Michelle Rainka, Traci Aladeen, Erica S. Westphal, Amir Mazhari, Laszlo Mechtler
First published April 9, 2019,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 92 no. 15 Supplement P5.2-106
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 9, 2019.
Copyright & Usage: 
© 2019

Author Disclosures

    1. Katelyn McCormack1,
    2. Emily Lewandowski2,
    3. Michelle Rainka1,
    4. Traci Aladeen1,
    5. Erica S. Westphal1,
    6. Amir Mazhari1 and
    7. Laszlo Mechtler1
  1. Katelyn McCormack1,
  2. Emily Lewandowski2,
  3. Michelle Rainka1,
  4. Traci Aladeen1,
  5. Erica S. Westphal1,
  6. Amir Mazhari1 and
  7. Laszlo Mechtler1
  1. 1Dent Neurologic Institute Amherst NY United States
  2. 2Pharmacy, Kaleida Health Buffalo NY United States

Article usage

Article usage: April 2019 to June 2019

AbstractFullPdfSource
Apr 201994400Highwire
May 2019106800Highwire
Jun 201936000Highwire

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me